These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15048063)

  • 21. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
    Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
    Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
    Ishitsuka K; Tsukasaki K; Tamura K
    Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
    Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
    Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells.
    Abou-Merhi R; Khoriaty R; Arnoult D; El Hajj H; Dbouk H; Munier S; El-Sabban ME; Hermine O; Gessain A; de Thé H; Mahieux R; Bazarbachi A
    Leukemia; 2007 Aug; 21(8):1792-801. PubMed ID: 17568816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
    Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
    Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.
    Evens AM; Ziegler SL; Gupta R; Augustyniak C; Gordon LI; Mehta J
    Clin Lymphoma Myeloma; 2007 Jul; 7(7):472-4. PubMed ID: 17875237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
    Bazarbachi A; Nasr R; El-Sabban ME; Mahé A; Mahieux R; Gessain A; Darwiche N; Dbaibo G; Kersual J; Zermati Y; Dianoux L; Chelbi-Alix MK; de Thé H; Hermine O
    Leukemia; 2000 Apr; 14(4):716-21. PubMed ID: 10764160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.
    Leoni F; Gianfaldoni G; Annunziata M; Fanci R; Ciolli S; Nozzoli C; Ferrara F
    Haematologica; 2002 May; 87(5):485-9. PubMed ID: 12010661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.
    Ratner L; Harrington W; Feng X; Grant C; Jacobson S; Noy A; Sparano J; Lee J; Ambinder R; Campbell N; Lairmore M;
    PLoS One; 2009; 4(2):e4420. PubMed ID: 19204798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.
    Ishitsuka K; Katsuya H; Toyota T; Ishizu M; Kunami N; Fujita M; Sasaki H; Takamatsu Y; Uchiyama M; Fujikane H; Ogata K; Hara S; Tamura K
    Int J Hematol; 2010 Dec; 92(5):762-4. PubMed ID: 21080125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
    Soignet SL; Maslak P; Wang ZG; Jhanwar S; Calleja E; Dardashti LJ; Corso D; DeBlasio A; Gabrilove J; Scheinberg DA; Pandolfi PP; Warrell RP
    N Engl J Med; 1998 Nov; 339(19):1341-8. PubMed ID: 9801394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult T-cell leukemia-lymphoma.
    Tsukasaki K
    Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Hachiman M; Yoshimitsu M; Ezinne C; Kuroki A; Kozako T; Arima N
    Oncol Lett; 2018 Jul; 16(1):1305-1311. PubMed ID: 30061950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
    Matutes E; Taylor GP; Cavenagh J; Pagliuca A; Bareford D; Domingo A; Hamblin M; Kelsey S; Mir N; Reilly JT
    Br J Haematol; 2001 Jun; 113(3):779-84. PubMed ID: 11380470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung infiltration of adult T-cell leukemia cells following the administration of arsenic trioxide. Lung infiltration of ATL by AS(2)O(3).
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Kawamura T; Obara S; Tanaka J; Asaka M; Imamura M; Masauzi N
    Med Hypotheses; 2006; 66(1):201-2. PubMed ID: 16165312
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.
    El Eit RM; Iskandarani AN; Saliba JL; Jabbour MN; Mahfouz RA; Bitar NM; Ayoubi HR; Zaatari GS; Mahon FX; De Thé HB; Bazarbachi AA; Nasr RR
    Int J Cancer; 2014 Feb; 134(4):988-96. PubMed ID: 23934954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
    Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
    Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
    Litzow MR; Lee S; Bennett JM; Dewald GW; Gallagher RE; Jain V; Paietta EM; Racevskis J; Rousey SR; Mazza JJ; Tallman MS
    Haematologica; 2006 Aug; 91(8):1105-8. PubMed ID: 16870552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.
    Merle H; Hage R; Meniane JC; Deligny C; Plumelle Y; Donnio A; Jean-Charles A
    Retina; 2016 Jul; 36(7):1364-71. PubMed ID: 26716955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.